179 related articles for article (PubMed ID: 17416022)
21. THELEP controlled clinical trials in lepromatous leprosy.
Lepr Rev; 1983 Sep; 54(3):167-76. PubMed ID: 6355720
[No Abstract] [Full Text] [Related]
22. Evolution of the modern chemotherapy of leprosy.
Levy L
Lepr Rev; 1983 Jun; Spec No():69-83. PubMed ID: 6350773
[No Abstract] [Full Text] [Related]
23. Committee 4: workshop on experimental chemotherapy of leprosy.
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
[No Abstract] [Full Text] [Related]
24. Chemotherapy of leprosy for control programmes: scientific basis and practical application.
Rees RJ
Lepr Rev; 1983 Jun; 54(2):81-7. PubMed ID: 6888143
[No Abstract] [Full Text] [Related]
25. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
26. [Hansen's disease: case report and review of literature].
Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
[TBL] [Abstract][Full Text] [Related]
27. [Suspected leprosy].
Velázquez de Castro y Sagarra A; López Bueno R; Gómez Jiménez G
Aten Primaria; 1997 Jun; 20(2):107-8. PubMed ID: 9296648
[No Abstract] [Full Text] [Related]
28. Multi-drug therapy in leprosy: an effective method of control.
Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238
[TBL] [Abstract][Full Text] [Related]
29. Nodular rash in an Indonesian girl.
Prince JM; Janner D
Pediatr Infect Dis J; 2001 Nov; 20(11):1098-9, 1102-3. PubMed ID: 11734724
[No Abstract] [Full Text] [Related]
30. [Sensory-motor neuropathy: a slow and misleading case of leprosy].
Gabelle A; Vallat JM; Flageul B; Andre P; Camu W
Rev Neurol (Paris); 2008 Nov; 164(11):964-8. PubMed ID: 18808760
[TBL] [Abstract][Full Text] [Related]
31. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
32. A overview of ocular leprosy after 2 decades of multidrug therapy.
Lewallen S; Courtright P
Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
[No Abstract] [Full Text] [Related]
33. [Leprosy – an old infectious disease with unsolved matters].
Stock I
Med Monatsschr Pharm; 2016 Dec; 39(12):522-6. PubMed ID: 29979513
[TBL] [Abstract][Full Text] [Related]
34. Multi-drug therapy of leprosy.
Ramu G
Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
[No Abstract] [Full Text] [Related]
35. Screening of drugs for activity against Mycobacterium leprae.
Baohong J; Matsuo Y; Colston MJ
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
[No Abstract] [Full Text] [Related]
36. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
37. Dapsone-induced motor polyneuropathy in a patient with leprosy.
Pavithran K; Satish TC
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):262-3. PubMed ID: 9251603
[No Abstract] [Full Text] [Related]
38. The diagnosis and management of dapsone-resistant leprosy.
Waters MF
Lepr Rev; 1977 Jun; 48(2):95-105. PubMed ID: 331001
[No Abstract] [Full Text] [Related]
39. Effect of zafirlukast on leprosy reactions.
Vides EA; Cabrera A; Ahern KP; Levis WR
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):71-5. PubMed ID: 10407633
[No Abstract] [Full Text] [Related]
40. Dapsone hypersensitivity or viral exanthem?
Ramam M; Srivastava P
Acta Derm Venereol; 2004; 84(4):334-5; author reply 335-6. PubMed ID: 15339092
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
